AstraZeneca and MSD said their application for a drug used to treat advanced ovarian cancer had been accepted and granted priority review in the US....
14/01/2020 Games Workshop Group PLC (GAW) 21/01/2020 Joules Group Plc (JOUL) 21/01/2020 Sensyne Health Plc (SENS) 23/01/2020 NCC Group PLC (NCC) 23/01/2020...
Stephen Boyd, Financial Director, sold post-exercise 382,075 shares in the company on the 9th January 2020 at a price of 98.35p. The Director now holds...